Price:
Rs. 45,000.00
Sample Type: null
Fasting Not Required
Notes: I8450
Frequently Asked Questions (FAQ's):
What does the Immunotherapy Panel (TMB + MSI) include?
This test evaluates Tumor Mutational Burden and Microsatellite Instability, key markers that help determine how effectively a patient may respond to immunotherapy.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses advanced Next-Generation Sequencing platforms to analyze tumor tissue with high sensitivity and reliability.
Who should take this test?
Cancer patients being considered for immunotherapy or those with recurrent, metastatic, or treatment-resistant tumors are ideal candidates.
What sample is required for this test?
FFPE tumor tissue blocks or tissue slides are required for processing at Metropolis Healthcare.
How do TMB and MSI results support treatment planning?
High TMB or MSI-High status indicates better response potential to immune checkpoint inhibitors like PD-1, PD-L1, or CTLA-4 targeted therapies.
How long do results take at Metropolis Healthcare?
Typically, results are available within 12–15 working days depending on sample complexity.
Is this test useful for all types of cancers?
Yes, it is valuable across a broad range of solid tumors including colorectal, lung, gastric, breast, and endometrial cancers.
Does Metropolis Healthcare offer related genomic testing?
Yes, Metropolis Healthcare provides extensive genomic oncology panels including HRD Score, Liquid Biopsy NGS, and comprehensive somatic mutation profiling